Patient Seminar 2017: Program
The 2017 program featured a wide range of topics, including the latest updates on HPV Vaccination & Screening and New Treatment Options in Ovarian Cancer as well as key issues on Clinical Trials, Development of a New Drug/ New Treatment and Management of Survivorship.
The new format of roundtable discussions with leading experts on What is New in Gynaecological Cancer? and Let the Expert NGOs Speak, stimulated the interaction between patient advocacy representatives and the experts.
Special sessions on the late effects of treatment and the collaboration between Patient Advocacy Groups and ESGO were presented on the second day of the program.
Explore the presentations below of the 2-days Patient Seminar Program.
TRACK SESSIONS 1 :
Chairs: Cristiana Sessa, Switzerland and Birthe Lemley, Denmark
What Is a Clinical Trial? Development of a New Drug/ New Treatment
Cristiana Sessa, Switzerland and Birthe Lemley, Denmark
Management of Survivorship, Role of Repeated Controls and Rehabilitation
Heidi Donovan, USA
HPV Vaccination & Screening: What is it, Why it is important Health professionals voice, NGO’s voice, patient’s voice
Cervical Cancer Screening with HPV DNA: Up to Date Info From Europe
Murat Gultekin, Turkey
HPV Vaccination and Future of Cervical Cancer in Europe
Xavier Bosch, Spain
Why we can? Why we cannot? ENGAGe Perspective
Maude Anderssen, Sweden
TRACK SESSIONS 2 :
Chairs: Chairs: Denis Querleu (France) and Esra Urkmez (USA)
How Can The Patient Evaluate Quality of Care? ENGAGE Perspective
Denis Querleu, France and Birthe Lemley, Denmark
New Treatment Options in Ovarian Cancer
Mansoor Mirza, Denmark
TRACK SESSIONS 3:
Chairs: Chairs: Dina Kurdiani, Georgia and Ildikó Nagy-Tóth, Hungary
Late Effects of Treatment Including Lympaedema
Elisabeth Aval-Lundqvist, Sweden and Dina Kurdiani, Georgia
Alina Sturdza, Austria
Jalid Sehouli, Germany
Elisabeth Aval-Lundqvist, Sweden
Maria Papageorgiou, Greece